Cristina Tural

5.8k total citations
114 papers, 3.8k citations indexed

About

Cristina Tural is a scholar working on Epidemiology, Hepatology and Infectious Diseases. According to data from OpenAlex, Cristina Tural has authored 114 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 70 papers in Epidemiology, 64 papers in Hepatology and 53 papers in Infectious Diseases. Recurrent topics in Cristina Tural's work include Hepatitis C virus research (64 papers), HIV/AIDS drug development and treatment (43 papers) and Liver Disease Diagnosis and Treatment (35 papers). Cristina Tural is often cited by papers focused on Hepatitis C virus research (64 papers), HIV/AIDS drug development and treatment (43 papers) and Liver Disease Diagnosis and Treatment (35 papers). Cristina Tural collaborates with scholars based in Spain, United States and Germany. Cristina Tural's co-authors include Bonaventura Clotet, Guillem Sirera, Roger Paredes, Joan Romeu, Eugènia Negredo, Vincent Soriano, Miguel Ángel Martı́nez, Celestino Rey‐Joly, Lı́dia Ruiz and Sandra Franco and has published in prestigious journals such as Gastroenterology, PLoS ONE and Hepatology.

In The Last Decade

Cristina Tural

112 papers receiving 3.7k citations

Peers

Countries citing papers authored by Cristina Tural

Since Specialization

Citations

This map shows the geographic impact of Cristina Tural's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cristina Tural with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cristina Tural more than expected).

Fields of papers citing papers by Cristina Tural

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cristina Tural. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cristina Tural. The network helps show where Cristina Tural may publish in the future.

Co-authorship network of co-authors of Cristina Tural

This figure shows the co-authorship network connecting the top 25 collaborators of Cristina Tural. A scholar is included among the top collaborators of Cristina Tural based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cristina Tural. Cristina Tural is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Large-scale screening of circulating microRNAs in individuals with HIV-1 mono-infections reveals specific liver damage signatures 2018 ·Antiviral Research ·Sandra Franco, (unknown), Raquel Pluvinet, Beatriz Mothe, Lı́dia Ruiz, María Nevot, (unknown), (unknown), Susanna Aussó, Rosa M. Morillas, Lauro Sumoy, Miguel Ángel Martı́nez, Cristina Tural	9
2	Clinical progression of severely immunosuppressed HIV-infected patients depends on virological and immunological improvement irrespective of baseline status 2015 ·Journal of Antimicrobial Chemotherapy ·Elena Ferrer, Jordi Curto, Anna Esteve‐Codina, José M. Miró, Cristina Tural, Javier Murillas, Ferrán Segura, Pilar Barrufet, Jordi Casabona, Daniel Podzamczer	4
3	Faldaprevir and pegylated interferon α-2a/ribavirin in individuals co-infected with hepatitis C virus genotype-1 and HIV 2015 ·AIDS ·Douglas T. Dieterich, Mark Nelson, Vincent Soriano, Keikawus Arastéh, Josep M. Guardiola, Jürgen K. Rockstroh, Sanjay Bhagani, Montserrat Laguno, Cristina Tural, Patrick Ingiliz, Mamta K. Jain, Jerry O. Stern, (unknown), Richard Vinisko, Jens Kort	10
4	No detection of the NS5B S282T mutation in treatment-naïve genotype 1 HCV/HIV-1 coinfected patients using deep sequencing 2013 ·Journal of Clinical Virology ·Sandra Franco, María Casadellà, Marc Noguera-Julián, Bonaventura Clotet, Cristina Tural, Roger Paredes, Miguel Ángel Martı́nez	14
5	IFNL4 ss469415590 variant is a better predictor than rs12979860 of pegylated interferon-alpha/ribavirin therapy failure in hepatitis C virus/HIV-1 coinfected patients 2013 ·AIDS ·Sandra Franco, (unknown), Mariona Parera, Bonaventura Clotet, Cristina Tural, Miguel Ángel Martı́nez	28
6	Effect of Liver Fibrosis on Long-Term Mortality in HIV/Hepatitis C Virus-Coinfected Individuals Who Are Evaluated to Receive Interferon Therapies in the Highly Active Antiretroviral Therapy Era 2012 ·AIDS Research and Human Retroviruses ·(unknown), (unknown), Jordi Tor, (unknown), (unknown), (unknown), Roberto Muga, Antoni Jou, Isabel Ojanguren, (unknown), Bonaventura Clotet, Cristina Tural	6
7	Optimal timing for initiation of highly active antiretroviral therapy in treatment-naïve human immunodeficiency virus-1-infected individuals presenting with AIDS-defining diseases: the experience of the PISCIS Cohort 2012 ·Clinical Microbiology and Infection ·Christian Manzardo, Anna Esteve, (unknown), D Podzamczer, Javier Murillas, F. Segura, Lluís Force, Cristina Tural, Josep Vilaró, Àngels Masabeu, Felipe García, (unknown), Elena Ferrer, Melchor Riera, Gemma Navarro, Bonaventura Clotet, Josep M. Gatell, Jordi Casabona, José M. Miró	13
8	Plasma Epstein-Barr viral load measurement as a diagnostic marker of lymphoma in HIV-infected patients 2010 ·Medicina Clínica ·José‐Tomás Navarro, Águeda Hernández, Jesús Rodríguez-Manzano, José Luís Mate, Javier Grau, Mireia Morgades, Elisa Martró, Cristina Tural, Josep‐María Ribera, Lurdes Matas	8
9	Determinants of HIV Progression and Assessment of the Optimal Time to Initiate Highly Active Antiretroviral Therapy 2008 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Ángeles Jaén, Anna Esteve, Josep M. Miró, Cristina Tural, Alexandra Montoliu, Elena Ferrer, Melcior Riera, Ferrán Segura, Lluís Force, Omar Sued, Josep Vilaró, Felipe García, Àngels Masabeu, Jordi Altés, Bonaventura Clotet, Daniel Podzamczer, Javier Murillas, Gemma Navarro, Josep M. Gatell, Jordi Casabona	44
10	Evolution of Cervical Cytologic Changes among HIV-Infected Women with Normal Cytology in the HAART Era 2007 ·AIDS Research and Human Retroviruses ·Guillem Sirera, Sebastián Videla, Raquel López-Blázquez, Mariona Llatjós, Antoni Tarrats, Eva Castellà, Núria Grané, (unknown), Cristina Tural, Celestino Rey‐Joly, Bonaventura Clotet	10
11	Detection of hepatitis C virus antibodies in oral fluid specimens for prevalence studies 2007 ·European Journal of Clinical Microbiology & Infectious Diseases ·Victoria González, Elisa Martró, Cinta Folch, Anna Esteve, Lurdes Matas, Alexandra Montoliu, Joan Ramón Grifols, Ferrán Bolao, Cristina Tural, Roberto Muga, John Parry, V. Ausina, Jordi Casabona	26
12	Poor Response to Hepatitis C Virus (HCV) Therapy in HIV- and HCV-Coinfected Patients Is Not Due to Lower Adherence to Treatment 2006 ·AIDS Research and Human Retroviruses ·Ricard Solà, (unknown), Silvia Montoliu, Cristina Tural, Lluís Force, (unknown), (unknown), (unknown), S. Coll, Daniel Fuster, Pilar Barrufet, Guillem Sirera, (unknown), Bonaventura Clotet, Ramón Planas	20
13	Advanced Liver Fibrosis in HIV/HCV-Coinfected Patients on Antiretroviral Therapy 2004 ·AIDS Research and Human Retroviruses ·Daniel Fuster, Ramón Planas, Roberto Muga, (unknown), Justiniano Santos, Jordi Tor, Guillem Sirera, (unknown), Anna Salas, Eduard Cabré, Isabel Ojanguren, (unknown), Celestino Rey‐Joly, Bonaventura Clotet, Cristina Tural	44
14	Influence of Prior Structured Treatment Interruptions on the Length of Time without Antiretroviral Treatment in Chronically HIV-Infected Subjects 2004 ·AIDS Research and Human Retroviruses ·José Moltó, Lı́dia Ruiz, Joan Romeu, Javier Martínez‐Picado, Eugènia Negredo, Cristina Tural, Guillem Sirera, Bonaventura Clotet	12
15	Time on antiretroviral therapy is a protective factor for liver fibrosis in HIV and hepatitis C virus (HCV) co‐infected patients 2003 ·Journal of Viral Hepatitis ·Cristina Tural, Daniel Fuster, Jordi Tor, Isabel Ojanguren, G. Sirera, (unknown), (unknown), Ramón Planas, Celestino Rey‐Joly, Bonaventura Clotet	81
16	Recomendaciones para la profilaxis postexposición no ocupacional al VIH 2002 ·Enfermedades Infecciosas y Microbiología Clínica ·Jesús Almeda, Jordi Casabona, Alejandro Allepuz, Felipe García, Jorge del Romero, Cristina Tural, Joan Colom, Ferrán Bolao, Magda Campins, (unknown), Lluís Force, (unknown), (unknown)	12
17	Prospective Randomized Two-Arm Controlled Study To Determine the Efficacy of a Specific Intervention To Improve Long-Term Adherence to Highly Active Antiretroviral Therapy 2000 ·JAIDS Journal of Acquired Immune Deficiency Syndromes ·Albert Tuldrà, Carmina R. Fumaz, (unknown), Ramón Bayés, Albert Goday, Montserrat Balagué, Anna Bonjoch, Antoni Jou, Eugènia Negredo, Roger Paredes, (unknown), Joan Romeu, Guillem Sirera, Cristina Tural, David M. Burger, Bonaventura Clotet	197
18	Structured treatment interruption in chronically HIV-1 infected patients after long-term viral suppression 2000 ·AIDS ·Lı́dia Ruiz, Javier Martínez‐Picado, Joan Romeu, Roger Paredes, (unknown), Sílvia Marfil, Eugènia Negredo, Guillem Sirera, Cristina Tural, Bonaventura Clotet	172
19	Efficacy of triple combination therapy with zidovudine (ZDV) plus zalcitabine (ddC) plus lamivudine (3TC) versus double (ZDV+3TC) combination therapy in patients previously treated with ZDV+ddC 1996 ·AIDS ·Lı́dia Ruiz, Joan Romeu, Javier Martínez‐Picado, Jean‐Claude Schmit, Anne–Mieke Vandamme, Montserrat Balagué, Cecilia Cabrera, Teresa Puig, Cristina Tural, (unknown), Guillem Sirera, Erik De Clercq, Bonaventura Clotet	20
20	Anti-neutrophil cytoplasmic auto-antibodies-associated vasculitis with pulmonary and renal involvement 1993 ·European Journal of Pediatrics ·Guillem Pintos‐Morell, (unknown), (unknown), Cristina Tural, Elena Abad, (unknown), (unknown)	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact